Merus N.V. CS (MRUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRUS | BMY | AMGN | GILD | REGN |
| Company | Merus N.V. CS | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 42.32 | 48.36 | 269.93 | 68.27 | 915.37 |
| High | 42.41 | 49.10 | 270.93 | 68.46 | 921.12 |
| Low | 40.66 | 48.12 | 264.35 | 67.70 | 895.09 |
| Last | 41.27 | 48.51 | 265.51 | 67.75 | 898.56 |
| Change | -0.58 | +0.23 | -1.77 | -0.32 | -6.14 |
| % Change | -1.39% | +0.48% | -0.66% | -0.47% | -0.68% |
| Volume | 270,900 | 11,943,600 | 1,740,100 | 7,717,800 | 656,400 |
| 20-Day Average Volume | 497,180 | 11,927,375 | 2,348,660 | 6,525,295 | 422,565 |
| Previous Close | 41.85 | 48.28 | 267.28 | 68.07 | 904.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 44.29 | 51.53 | 274.13 | 71.23 | 948.80 |
| 20-Day Raw Stochastic | 8.80% | 6.14% | 4.81% | 1.95% | 4.12% |
| 20-Day Relative Strength | 42.61% | 36.92% | 38.68% | 31.69% | 32.80% |
| Weighted Alpha | +90.23 | -29.74 | +5.78 | -22.75 | +12.74 |
| Today's Opinion | 40% Buy | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 40% Buy | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 80% Buy | 8% Sell | 8% Sell | 40% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.23% since 04/08/24 | -5.07% since 04/08/24 | -1.37% since 04/08/24 | -2.41% since 04/08/24 | -4.25% since 04/08/24 |
| Low | 40.66 on 04/15/24 | 48.12 on 04/15/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 895.09 on 04/15/24 |
| High | 44.37 on 04/09/24 | 51.68 on 04/09/24 | 273.00 on 04/11/24 | 69.95 on 04/09/24 | 949.20 on 04/09/24 |
| 1-Month | |||||
| %Chg | -5.99% since 03/15/24 | -7.32% since 03/15/24 | -1.25% since 03/15/24 | -8.06% since 03/15/24 | -6.83% since 03/15/24 |
| Low | 40.66 on 04/15/24 | 48.12 on 04/15/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 895.09 on 04/15/24 |
| High | 47.59 on 03/22/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | +26.63% since 01/12/24 | -3.58% since 01/12/24 | -13.38% since 01/12/24 | -21.57% since 01/12/24 | -3.71% since 01/12/24 |
| Low | 31.27 on 01/18/24 | 47.58 on 02/06/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 895.09 on 04/15/24 |
| High | 52.03 on 03/01/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +95.59% since 10/13/23 | -14.10% since 10/13/23 | -6.54% since 10/13/23 | -12.75% since 10/13/23 | +7.02% since 10/13/23 |
| Low | 19.81 on 10/30/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 67.62 on 04/12/24 | 769.19 on 10/27/23 |
| High | 52.03 on 03/01/24 | 57.65 on 10/17/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,456,092 | 97,851,920 | 143,240,432 | 84,752,392 | 99,301,680 |
| Shares Outstanding, K | 58,688 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 43,950,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -154,940,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 8,940,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -60,150,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.10 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.09 on 02/28/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.44 | 14.33 | 10.13 | 24.07 |